NCT06963762Not yet recruiting
The Effect of Mirror Therapy Applied to Stroke Patients on Motor-Sensory Status and Quality of Life
Source: ClinicalTrials.gov · Last updated 9 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Purpose: The research will be conducted to evaluate the effect of Mirror Therapy applied to Stroke Patients on motor-sensory status and quality of life. Method: The research will be carried out as a randomized controlled experimental study at Bilecik Training and Research Hospital and Bozüyük State Hospital between 01.08.2024-01.05.2025. The population of the research consists of 350 people. Individuals will be distributed to the experimental (30) and control (30) groups by simple randomization method. In collecting research data; The patient introduction form, Brunnstrom Staging and SF-36 Quality of Life Scale will be administered to the patients in both groups by the researcher using face-to-face interview technique (pre-test). Patients in the experimental group will be informed about mirror therapy. In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks. Patients in the control group will only receive conventional rehabilitation for 30 minutes, 4 times a week for 4 weeks. At the end of the 4th week, patients in both groups will be administered Brunnstrom Staging and SF-36 Quality of Life Scale (posttest). If both groups are discharged before 4 weeks, the planned practices will continue at home.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 10 Apr 2025
- Start date
- May 2025
- Primary completion date
- Jan 2026
- Lead sponsor
- Ataturk University
- Diseases
- Stroke
- NCT number
- NCT06963762
What you commit to
- Study type: Interventional
- Planned participants: 60
- From May 2025 to the primary completion date, Jan 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Being under 18 years of age
Other
- Upper extremity Stage 2 and below in Brunnstrom staging
- In Brunnstrom staging, Lower extremity Stage 2 and below
Who the study is looking for
- Being literate,
- Being over the age of 18,
- Having sufficient communication skills to answer oral and written questions and follow instructions,
- Having been diagnosed with a stroke and at least 6 days have passed since it occurred,
- Not having severe vision problems,
- Not having a vertigo problem,
- Not having been diagnosed with epilepsy,
- Upper extremity Stage 2 and above in Brunnstrom staging
- Lower extremity Stage 2 and above in Brunnstrom staging
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.